Sagebrush Inn & Suites Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Atherosclerosis: Lessons Learned and Concepts Challenged (B2)

Scientific Organizers: Laura F. Michael, Gerard Pasterkamp and Sekar Kathiresan


February 4—8, 2018

Sagebrush Inn & Suites, Taos, New Mexico, USA


Sponsored by Amgen Inc., MedImmune and Novo Nordisk A/S


Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Oct 5, 2017 [details]
Discounted Abstract Deadline: Oct 5, 2017 [details]
Abstract Deadline: Nov 7, 2017 [details]
Discounted Registration Deadline: Dec 7, 2017 [details]

Click here to view Cancellation Policy

Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2018-B2 "Atherosclerosis: Lessons Learned and Concepts Challenged" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On October 5, 2017 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After October 5, 2017 until December 24, 2017 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
October 5, 2017 n/a
Discounted NON-STUDENT Registration
More details
Before and On December 7, 2017 820.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After December 7, 2017 1020.00 USD
Discounted STUDENT Registration
More details
Before and On December 7, 2017 595.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After December 7, 2017 795.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: October 5, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is November 7, 2017)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: October 5, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: November 7, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is October 5, 2017)

Discounted Registration Deadline: December 7, 2017

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 820.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 595.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1020.00 USD*
Student Registration Fee: 795.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, February 4 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, February 8 with a closing plenary session from 17:00 to 18:30, followed by a social hour and entertainment. We recommend return travel on Friday, February 9 in order to fully experience the meeting.

SUNDAY, FEBRUARY 4

16:00—20:00
Arrival and Registration

Sagebrush Lobby & Cantina
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Sagebrush Lobby & Cantina

MONDAY, FEBRUARY 5

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—11:00
The Natural History of Atherosclerotic Disease
Registered attendees can view abstracts starting on 01/04/2018

Chamisa Ballroom 1
* Daniel J. Rader, University of Pennsylvania, USA

Peter Libby, Brigham and Women's Hospital, USA
Requiem for the Vulnerable Plaque, Challenging Current Concepts

Sekar Kathiresan, Massachusetts General Hospital, USA
Inherited Basis for Myocardial Infarction

Coffee Break

Gerard Pasterkamp, University Medical Center Utrecht, Netherlands
Geno-Phenotyping of the Vulnerable Plaque and Patient

Philippe Boucher, University of Strasbourg, France
Short Talk: Wnt5a Decreases mTORC1/SREBP2 Activity and Promotes Endosomal Cholesterol Trafficking to the ER in Mice and in Human Vascular Smooth Muscle Cells

Sumeet A. Khetarpal, University of Pennsylvania, USA
Short Talk: A Human APOC3 Missense Variant and Monoclonal Antibody Accelerate apoC-III Clearance and Lower Triglyceride-rich Lipoprotein Levels

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Chamisa Ballroom 2
13:00—22:00
Poster Viewing

Chamisa Ballroom 2
14:30—16:30
Workshop 1

Chamisa Ballroom 1
* Ira G. Schulman, University of Virginia Health System, USA

Liam Brunham, University of British Columbia, Canada
Genetic Regulation of HDL Cholesterol Levels during Sepsis

Ruchi Gupta, MedImmune/AstraZeneca, USA
LOX-1: The Cause of and Solution to Inflammation and Lipid Accumulation in Atherosclerosis

Anna Kerstin Emy Hultgardh, Lund University, Sweden
IL-22 Deficiency Reduces Formation of Advanced Atherosclerotic Carotid Plaques in ApoE-Deficient Mice

Ashok Kumar Kumawat, Orebro University, Sweden
Targeting IL-6/IL17A in Vascular Inflammation using Affibody Molecules

Anna Mathew, University of Michigan, USA
Myeloperoxidase-Derived Oxidants Damage Artery Wall Proteins in an Animal Model of Chronic Kidney Disease-Accelerated Atherosclerosis

Mulugeta Melkie Zegeye, Orebro University, Sweden
Activation of JAK/STAT3 and PI3K Pathways Are Crucial for MCP-1 Induction by IL6 Trans-Signaling in Human Endothelial Cells

Sean Allen, Northwestern University, USA
Targeted Inhibition of NF-κB in Mouse Models of Atherosclerosis Results in Sex-Dependent Immunomodulation

16:30—17:00
Coffee Available

Chamisa Lobby
17:00—19:15
Lipoprotein Risk Factors
Registered attendees can view abstracts starting on 01/04/2018

Chamisa Ballroom 1
* Laura F. Michael, Eli Lilly and Company, USA

Kiran Musunuru, University of Pennsylvania, USA
Therapeutic Genome Editing as a Cure for Atherosclerosis

Anne Tybjærg-Hansen, Copenhagen University Hospital, Denmark
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights from Epidemiology, Genetics, and Biology

Daniel J. Rader, University of Pennsylvania, USA
Functionalizing HDL Cholesterol

Marlys L. Koschinsky, Western University, Canada
Lipoprotein(a): Ready for Prime Time?

19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
19:30—22:00
Poster Session 1

Chamisa Ballroom 2

TUESDAY, FEBRUARY 6

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—11:00
Diabetes, Obesity and Atherosclerosis
Registered attendees can view abstracts starting on 01/04/2018

Chamisa Ballroom 1
* Siddhartha Jaiswal, Stanford University, USA

J. Mark Brown, Cleveland Clinic, USA
Selective Small Molecule Inhibition of Gut Microbial Enzymes for the Treatment of Cardiometabolic Disorders

Joerg Heeren, University Medical Center Hamburg-Eppendorf, Germany
Protective Role of Brown Adipose in Atherosclerosis Development

Coffee Break

Laura F. Michael, Eli Lilly and Company, USA
Diabetes and Atherosclerosis: Anti-Diabetic Agents that Improve Cardiovascular Outcomes

Robert C. Bauer, Columbia University, USA
Short Talk: Adipose Knockout of Tribbles-1, a GWAS Locus for Coronary Artery Disease, Reduces Plasma Lipids and Increases Circulating Adiponectin

Brian Parks, University of Wisconsin-Madison, USA
Journal of Lipid Research Junior Investigator Award: Short Talk: Leveraging Mouse Liver Co-Expression Networks and Human Lipid GWAS Data to Identify and Validate Cholesterol Metabolism Genes

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Chamisa Ballroom 2
13:00—22:00
Poster Viewing

Chamisa Ballroom 2
16:30—17:00
Coffee Available

Chamisa Lobby
17:00—19:00
The Inflammation Hypothesis
Registered attendees can view abstracts starting on 01/04/2018

Chamisa Ballroom 1
* Katey Rayner, University of Ottawa, Canada

Ziad Mallat, University of Cambridge, UK
Immune Modulation in Atherosclerosis

Jan Nilsson, Lund University, Sweden
Autoimmunity, Injury and Repair as Potential Targets for Intervention in Atherosclerosis

Paul M. Ridker, Brigham and Women's Hospital, Harvard Medical School, USA
Anti-inflammatory Therapies for Chronic Atherosclerosis

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
19:30—22:00
Poster Session 2

Chamisa Ballroom 2

WEDNESDAY, FEBRUARY 7

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—11:15
The Milieu Exterieur
Registered attendees can view abstracts starting on 01/04/2018

Chamisa Ballroom 1
* Gerard Pasterkamp, University Medical Center Utrecht, Netherlands

Sudha B. Biddinger, Boston Children's Hospital, Harvard Medical School, USA
Beyond Hyperglycemia: Novel Mediators of Diabetes-Associated Cardiovascular Disease

Seppo Yla-Herttuala, University of Eastern Finland, Finland
Epigenetics, VEGFs and Noncoding RNAs in Atherosclerosis and Angiogenesis

Coffee Break

Robert E. Gerszten, Beth Israel Deaconess Medical Center, USA
Translating Exercise into Reduced Atherosclerosis Burden

Salim Yusuf, McMaster University, Canada
How Can We Reduce Premature CVD Globally in a Generation?

Brian Bennett, US Department of Agriculture, USA
Short Talk: Genetic and MicroRNA Association with the Cardiometabolic Disease Risk Factor TMAO

Michael C. Petriello, University of Kentucky, USA
Short Talk: Serum Levels of Dioxin-Like Pollutants Are Positively Associated with the Cardiometabolic Disease Risk Biomarker Trimethylamine-N-oxide in Leaner Individuals

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

Chamisa Ballroom 2
13:00—22:00
Poster Viewing

Chamisa Ballroom 2
14:30—16:30
Workshop 2

Chamisa Ballroom 1
* Dominique P.V. de Kleijn, University Medical Center Utrecht, Netherlands

Camilla Gustafsen, Aarhus University, Denmark
Heparan Sulfate Proteoglycans Present PCSK9 to the LDL Receptor

Fan E. Mo, National Cheng Kung University, Taiwan
CCN1 and Its Receptor Integrin alpha6beta1 Instigate a Vicious Circle to Accelerate Disturbed Flow-Induced Atherosclerosis

Andrew J. Morris, University of Kentucky, USA
Functional Validation of PPAP2B Gene Variants as Determinants of Coronary Artery Disease Risk

Edward R. O'Brien, University of Calgary, Canada
Natural Antibodies to HSP27 Are Novel Biomarkers for Cardiovascular Health: HSP27 Immunization Attenuates PCSK9 Transcription and Atherogenesis

Ira G. Schulman, University of Virginia Health System, USA
Regulation of HDL Function and Inflammation by Liver X Receptors

Tapan Shah, Rutgers New Jersey Medical School, USA
Sex Specific Differences in Post-Transcriptional Gene Regulation of BMP2 in Cardiovascular Calcification

Vincent J. Venditto, University of Kentucky, USA
Anti-ApoA-I Antibody Profiles Predict Cardiovascular Disease Outcomes in Patients and in a Mouse Model of Atherosclerosis

Hong Yang, Meharry Medical College, USA
Upregulation of ABCA1 Transcription and Inhibition of ABCA1 Protein Degradation by VLDLR/apoER2 Pathway

16:30—17:00
Coffee Available

Chamisa Lobby
17:00—19:15
Crosstalk Among Organs
Registered attendees can view abstracts starting on 01/04/2018

Chamisa Ballroom 1
* Jan Nilsson, Lund University, Sweden

Viktoria Gusarova, Regeneron Pharmaceuticals, USA
ANGPTL3 Blockade as a Therapeutic Approach for Treatment of Dyslipidemia and Atherosclerosis

Lilach O. Lerman, Mayo Clinic, USA
New Concepts in Atherosclerotic Renovascular Disease: Current Status

Joachim Herz, University of Texas Southwestern Medical Center, USA
Multitasking Therapeutics: What Brain Development, Alzheimer’s Disease and Atherosclerosis Have in Common

Johan Lars Markus Björkegren, Icahn School of Medicine at Mount Sinai, USA
Cardiometabolic Risk Loci Share Downstream Cis- and Trans-Gene Regulation Across Tissues and Diseases

19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
19:30—22:00
Poster Session 3

Chamisa Ballroom 2

THURSDAY, FEBRUARY 8

07:00—08:00
Breakfast

Sagebrush Lobby & Cantina
08:00—09:00
Keynote Address
Registered attendees can view abstracts starting on 01/04/2018

Chamisa Ballroom 1
* Sekar Kathiresan, Massachusetts General Hospital, USA

George D. Yancopoulos, Regeneron Pharmaceuticals, Inc., USA
The Impact of PCKS9 on Treating Atherosclerosis

09:00—11:15
Models and Biomarkers for Atherosclerotic Disease
Registered attendees can view abstracts starting on 01/04/2018

Chamisa Ballroom 1
* Viktoria Gusarova, Regeneron Pharmaceuticals, USA

Jacob Fog Bentzon, Centro Nacional de Investigaciones Cardiovasculares, Spain
Gene-Modified Minipigs: Applications in Atherosclerosis Imaging

Coffee Break

Lesca Miriam Holdt, University Hospital, LMU Munich, Germany
Circular RNA in Atherosclerosis

Katey Rayner, University of Ottawa, Canada
New Inflammatory Drivers and Biomarkers of Atherosclerosis

Kelsey E. Jarrett, Baylor College of Medicine, USA
Short Talk: Somatic Genome Editing of Ldlr with AAV-CRISPR Is a Rapid Method for Atherosclerosis Investigation

11:15—17:00
On Own for Lunch

14:30—16:30
Workshop 3

Chamisa Ballroom 1
* Thomas Beyer, Eli Lilly and Company, USA

Maria Ines Azambuja, Universidade Federal do Rio Grande do Sul, Brazil
The Information that We Need to Advance Knowledge on Atherogenesis Exists and It Is Stored as Levels and Trends of Mortality over the Last Century: Influenza is the Key to Retrieve It

Dominique P.V. de Kleijn, University Medical Center Utrecht, Netherlands
Diagnosis of Atherosclerotic Coronary Heart Disease using Plasma Extracellular Vesicle Proteins

Trine Pagh Ludvigsen, Novo Nordisk A/S, Denmark
Effect of Statin Treatment Compared to Dietary Cessation on Aortic Plaque Size and Inflammation in a Diet-Induced Atherosclerotic Göttingen Minipig Model

Ananthi Rajamoorthi, St. Louis University School of Medicine, USA
Therapeutic Silencing of CIDEC/Fsp27 Is Atheroprotective in Ldlr-/- Mice

Divya Sagar, MedImmune, USA
Soluble LOX-1: A Potential Biomarker for SLE and Cardiovascular Comorbidity

James Wingrove, CardioDx, USA
The Added Value of a Multi-Omics Approach for the Evaluation of Patients with Suspected Obstructive Coronary Artery Disease

Jifeng Zhang, University of Michigan, USA
Attenuated Atherosclerosis in Human Apolipoprotein A-II knockin Rabbits

16:30—17:00
Coffee Available

Chamisa Lobby
17:00—18:00
Emerging Fields of Research
Registered attendees can view abstracts starting on 01/04/2018

Chamisa Ballroom 1
* Sekar Kathiresan, Massachusetts General Hospital, USA

Hester den Ruijter, University Medical Center, Utrecht, Netherlands
Sex Differences in Cardiovascular Disease

Siddhartha Jaiswal, Stanford University, USA
Clonal Hematopoiesis in Aging and Atherosclerotic Cardiovascular Disease

18:00—18:30
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/04/2018

Chamisa Ballroom 1
18:30—19:30
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Chamisa Ballroom 2
19:30—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Chamisa Ballroom 2

FRIDAY, FEBRUARY 9

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

Amgen Inc. MedImmune
Novo Nordisk A/S
 

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1 R13 HL140612-01

Funding for this conference was made possible (in part) by 1 R13 HL140612-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Regeneron Pharmaceuticals, Inc.


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676